Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

MediWound completes enrollment in phase II pediatric study of NexoBrid

Oct. 30, 2020

First patient dosed in phase II study of BBP-589

Oct. 29, 2020

Phase II study of SHR-0302 in atopic dermatitis meets primary and secondary endpoints

Oct. 27, 2020

First patient dosed in phase IIa study of ATI-1777

Oct. 21, 2020

Genfleet Therapeutics patents RIP-1 inhibitors

Oct. 16, 2020

AnaptysBio reports topline data from phase II GALLOP study of imsidolimab in GPP

Oct. 14, 2020

Hisamitsu Pharmaceutical initiates phase III study of HP-5070 in Japan

Oct. 9, 2020

IDMC recommends piclidenoson psoriasis study continue, rheumatoid arthritis trial end

Oct. 8, 2020

Galapagos begins patient dosing with GLPG-3970 in psoriasis

Oct. 1, 2020

Arcutis reports topline phase II data on roflumilast topical foam for seborrheic dermatitis

Sep. 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026